Journavx (suzetrigine) - Vertex
Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery (clinicaltrials.gov) - Sep 26, 2026 - P4 | N=230 | Not yet recruiting | Sponsor: University of Minnesota 
New P4 trial • Genetic Disorders • Head and Neck Cancer • Oncology • Pain • Skin Cancer
http://clinicaltrials.gov/ct2/show/NCT07843134
 
Sep 26, 2026
 
Prev Next